A blog about chemistry, drug development, science, and technology
I find it very different and quite interesting that several AIDS drug manufacturers have said they are actually going to help generic manufacturers in India to make generic versions of some AIDS drugs.
Gilead offers secrets to AIDS drug - Marketplace by Bloomberg - International Herald Tribune:
I’d be interested to hear what the details are as I’m sure they aren’t doing this without some sort of compensation (upfront payment or royalties?).
Hear is a quote from Bristol-Myers Squibb.
Bristol-Myers says it will assist two manufacturers, the India-based Emcure Pharmaceuticals and Aspen Pharmacare in South Africa, in making copies of its AIDS pills. “We didn’t just send them the owner’s manual, but we also sent them our technicians to work in their labs,” said Donne Newbury, director of global HIV access programs at Bristol-Myers.
I think this sort of cooperation should be encouraged for just these sorts of situations. Making affordable medications for the rest of the world is going to be a major challenge in the 21st century.
Technorati Tags: aids drugs, BMS, Bristol-Myers Squibb, drug development, Gilead
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.102 seconds